| Year |
Citation |
Score |
| 2023 |
Glotfelty EJ, Tovar-Y-Romo LB, Hsueh SC, Tweedie D, Li Y, Harvey BK, Hoffer BJ, Karlsson TE, Olson L, Greig NH. The RhoA-ROCK1/ROCK2 Pathway Exacerbates Inflammatory Signaling in Immortalized and Primary Microglia. Cells. 12. PMID 37408199 DOI: 10.3390/cells12101367 |
0.516 |
|
| 2023 |
Glotfelty EJ, Hsueh SC, Claybourne Q, Bedolla A, Kopp KO, Wallace T, Zheng B, Luo Y, Karlsson TE, McDevitt RA, Olson L, Greig NH. Microglial Nogo delays recovery following traumatic brain injury in mice. Glia. PMID 37401784 DOI: 10.1002/glia.24436 |
0.572 |
|
| 2023 |
Kopp KO, Greer ME, Glotfelty EJ, Hsueh SC, Tweedie D, Kim DS, Reale M, Vargesson N, Greig NH. A New Generation of IMiDs as Treatments for Neuroinflammatory and Neurodegenerative Disorders. Biomolecules. 13. PMID 37238617 DOI: 10.3390/biom13050747 |
0.456 |
|
| 2022 |
Kopp KO, Glotfelty EJ, Li Y, Greig NH. Glucagon-like Peptide-1 (GLP-1) Receptor Agonists and Neuroinflammation: Implications for Neurodegenerative Disease Treatment. Pharmacological Research. 106550. PMID 36372278 DOI: 10.1016/j.phrs.2022.106550 |
0.477 |
|
| 2022 |
Lecca D, Jung YJ, Scerba MT, Hwang I, Kim YK, Kim S, Modrow S, Tweedie D, Hsueh SC, Liu D, Luo W, Glotfelty E, Li Y, Wang JY, Luo Y, et al. Role of chronic neuroinflammation in neuroplasticity and cognitive function: A hypothesis. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 35234334 DOI: 10.1002/alz.12610 |
0.428 |
|
| 2021 |
Li Y, Glotfelty EJ, Karlsson T, Fortuno LV, Harvey BK, Greig NH. The metabolite GLP-1 (9-36) is neuroprotective and anti-inflammatory in cellular models of neurodegeneration. Journal of Neurochemistry. PMID 34569615 DOI: 10.1111/jnc.15521 |
0.475 |
|
| 2021 |
McNutt PM, Vazquez-Cintron EJ, Tenezaca L, Ondeck CA, Kelly KE, Mangkhalakhili M, Machamer JB, Angeles CA, Glotfelty EJ, Cika J, Benjumea CH, Whitfield JT, Band PA, Shoemaker CB, Ichtchenko K. Neuronal delivery of antibodies has therapeutic effects in animal models of botulism. Science Translational Medicine. 13. PMID 33408188 DOI: 10.1126/scitranslmed.abd7789 |
0.583 |
|
| 2020 |
Yu SJ, Chen S, Yang YY, Glotfelty EJ, Jung J, Kim HK, Choi HI, Choi DS, Hoffer BJ, Greig NH, Wang Y. PT320, Sustained-Release Exendin-4, Mitigates L-DOPA-Induced Dyskinesia in a Rat 6-Hydroxydopamine Model of Parkinson's Disease. Frontiers in Neuroscience. 14: 785. PMID 32848559 DOI: 10.3389/Fnins.2020.00785 |
0.489 |
|
| 2020 |
Glotfelty EJ, Olson L, Karlsson TE, Li Y, Greig NH. Glucagon-like peptide-1 (GLP-1)-based receptor agonists as a treatment for Parkinson's disease. Expert Opinion On Investigational Drugs. 1-8. PMID 32412796 DOI: 10.1080/13543784.2020.1764534 |
0.556 |
|
| 2019 |
Greig NH, Lecca D, Hsueh SC, Nogueras-Ortiz C, Kapogiannis D, Tweedie D, Glotfelty EJ, Becker RE, Chiang YH, Hoffer BJ. (-)-Phenserine tartrate (PhenT) as a treatment for traumatic brain injury. Cns Neuroscience & Therapeutics. PMID 31828969 DOI: 10.1111/Cns.13274 |
0.537 |
|
| 2019 |
Li Y, Glotfelty EJ, Namdar I, Tweedie D, Olson L, Hoffer BJ, DiMarchi RD, Pick CG, Greig NH. Neurotrophic and neuroprotective effects of a monomeric GLP-1/GIP/Gcg receptor triagonist in cellular and rodent models of mild traumatic brain injury. Experimental Neurology. 113113. PMID 31730763 DOI: 10.1016/J.Expneurol.2019.113113 |
0.619 |
|
| 2019 |
Glotfelty EJ, Delgado T, Tovar-Y-Romo LB, Luo Y, Hoffer B, Olson L, Karlsson T, Mattson MP, Harvey B, Tweedie D, Li Y, Greig NH. Incretin Mimetics as Rational Candidates for the Treatment of Traumatic Brain Injury. Acs Pharmacology & Translational Science. 2: 66-91. PMID 31396586 DOI: 10.1021/acsptsci.9b00003 |
0.59 |
|
| 2018 |
Bader M, Li Y, Lecca D, Rubovitch V, Tweedie D, Glotfelty E, Rachmany L, Kim HK, Choi HI, Hoffer BJ, Pick CG, Greig NH, Kim DS. Pharmacokinetics and efficacy of PT302, a sustained-release Exenatide formulation, in a murine model of mild traumatic brain injury. Neurobiology of Disease. PMID 30471415 DOI: 10.1016/J.Nbd.2018.11.023 |
0.583 |
|
| 2018 |
Chen S, Yu SJ, Li Y, Lecca D, Glotfelty E, Kim HK, Choi HI, Hoffer BJ, Greig NH, Kim DS, Wang Y. Author Correction: Post-treatment with PT302, a long-acting Exendin-4 sustained release formulation, reduces dopaminergic neurodegeneration in a 6-Hydroxydopamine rat model of Parkinson's disease. Scientific Reports. 8: 13953. PMID 30209317 DOI: 10.1038/s41598-018-31455-w |
0.422 |
|
| 2018 |
Chen S, Yu SJ, Li Y, Lecca D, Glotfelty E, Kim HK, Choi HI, Hoffer BJ, Greig NH, Kim DS, Wang Y. Post-treatment with PT302, a long-acting Exendin-4 sustained release formulation, reduces dopaminergic neurodegeneration in a 6-Hydroxydopamine rat model of Parkinson's disease. Scientific Reports. 8: 10722. PMID 30013201 DOI: 10.1038/S41598-018-28449-Z |
0.512 |
|
| 2017 |
Vazquez-Cintron EJ, Beske PH, Tenezaca L, Tran BQ, Oyler JM, Glotfelty EJ, Angeles CA, Syngkon A, Mukherjee J, Kalb SR, Band PA, McNutt PM, Shoemaker CB, Ichtchenko K. Engineering Botulinum Neurotoxin C1 as a Molecular Vehicle for Intra-Neuronal Drug Delivery. Scientific Reports. 7: 42923. PMID 28220863 DOI: 10.1038/Srep42923 |
0.593 |
|
| 2016 |
McNutt PM, Tuznik KM, Glotfelty EJ, Nelson MR, Lyman ME, Hamilton TA. Contributions of tissue-specific pathologies to corneal injuries following exposure to SM vapor. Annals of the New York Academy of Sciences. PMID 27310673 DOI: 10.1111/Nyas.13105 |
0.622 |
|
| 2015 |
Beske PH, Bradford AB, Grynovicki JO, Glotfelty EJ, Hoffman KM, Hubbard KS, Tuznik KM, McNutt PM. Botulinum and tetanus neurotoxin-induced blockade of synaptic transmission in networked cultures of human and rodent neurons. Toxicological Sciences : An Official Journal of the Society of Toxicology. PMID 26615023 DOI: 10.1093/Toxsci/Kfv254 |
0.6 |
|
| 2013 |
McNutt P, Tuznik K, Nelson M, Adkins A, Lyman M, Glotfelty E, Hughes J, Hamilton T. Structural, morphological, and functional correlates of corneal endothelial toxicity following corneal exposure to sulfur mustard vapor. Investigative Ophthalmology & Visual Science. 54: 6735-44. PMID 24045986 DOI: 10.1167/Iovs.13-12402 |
0.61 |
|
| Show low-probability matches. |